
Legend Biotech Investor Relations Material
Latest events

Q3 2024
Legend Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Legend Biotech Corp
Access all reports
Legend Biotech Corp is a clinical-stage biopharmaceutical company, focusing on the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications. The company's flagship product candidate is LCAR-B38M, a chimeric antigen receptor (CAR) therapy aimed at treating multiple myeloma (MM). Besides, Legend Biotech has developed a diverse portfolio of earlier-stage autologous CAR-T product candidates targeting a variety of cancers, including Non-Hodgkin's Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. The company is headquartered in Somerset, New Jersey, with its shares listed on the Nasdaq.
Key slides for Legend Biotech Corp


43rd Annual J.P. Morgan Healthcare Conference 2025
Legend Biotech Corp


Q3 2024
Legend Biotech Corp
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
LEGN
Country
🇺🇸 United States